Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pasithea Therapeutics Corp.

0.7860
-0.0432-5.21%
Post-market: 0.7805-0.0055-0.70%19:19 EDT
Volume:291.70K
Turnover:230.29K
Market Cap:5.85M
PE:-0.08
High:0.8400
Open:0.7951
Low:0.7706
Close:0.8292
Loading ...
Jun 27, 2022

Major Issues Report

8-K/A [Amend] - Current report
Jun 24, 2022

Major Issues Report

8-K - Current report
Jun 24, 2022

Major Issues Report

8-K/A [Amend] - Current report
Jun 22, 2022

Major Issues Report

8-K - Current report
Jun 16, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 10, 2022

Major Issues Report

8-K - Current report
Jun 01, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 03, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2021

Major Issues Report

8-K - Current report
Dec 20, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 09, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 29, 2021

Major Issues Report

8-K - Current report
Nov 18, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals